| 000 | 01755 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513091820.0 | ||
| 264 | 0 | _c19960820 | |
| 008 | 199608s 0 0 eng d | ||
| 022 | _a0021-9258 | ||
| 024 | 7 |
_a10.1074/jbc.271.26.15782 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBalbín, M | |
| 245 | 0 | 0 |
_aFunctional analysis of a p21WAF1,CIP1,SDI1 mutant (Arg94 --> Trp) identified in a human breast carcinoma. Evidence that the mutation impairs the ability of p21 to inhibit cyclin-dependent kinases. _h[electronic resource] |
| 260 |
_bThe Journal of biological chemistry _cJun 1996 |
||
| 300 |
_a15782-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aArginine |
| 650 | 0 | 4 | _aBase Sequence |
| 650 | 0 | 4 |
_aBreast Neoplasms _xgenetics |
| 650 | 0 | 4 |
_aCarcinoma, Ductal, Breast _xgenetics |
| 650 | 0 | 4 | _aCell Cycle |
| 650 | 0 | 4 | _aCyclin D1 |
| 650 | 0 | 4 | _aCyclin-Dependent Kinase Inhibitor p21 |
| 650 | 0 | 4 |
_aCyclin-Dependent Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aCyclins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aDNA Primers _xchemistry |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 |
_aOncogene Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aPoint Mutation |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 | _aTryptophan |
| 700 | 1 | _aHannon, G J | |
| 700 | 1 | _aPendás, A M | |
| 700 | 1 | _aFerrando, A A | |
| 700 | 1 | _aVizoso, F | |
| 700 | 1 | _aFueyo, A | |
| 700 | 1 | _aLópez-Otín, C | |
| 773 | 0 |
_tThe Journal of biological chemistry _gvol. 271 _gno. 26 _gp. 15782-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1074/jbc.271.26.15782 _zAvailable from publisher's website |
| 999 |
_c8661804 _d8661804 |
||